Guanfacine Tablet, Extended Release
Product Images NDC 50090-7644

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 50090-7644). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure2 (Guanfacine 2figure)

A forest plot chart depicting fold change and 90% confidence intervals for Cmax and AUC pharmacokinetic parameters of guanfacine in the presence of various CYP3A4/5 inhibitors, inducers, and other drugs. It compares oral methylphenidate, lisdexamfetamine dimesylate, ketoconazole, fluconazole, rifampin, and efavirenz relative to reference values.*

FDA Label Image

Figure 3 (Guanfacine 3 Figure)

A fold change graph with 90% confidence intervals showing pharmacokinetic parameters Cmax and AUC for oral methylphenidate and lisdexamfetamine dimesylate. The x-axis represents change relative to reference from 0 to 2, with data points near 1 indicating no significant change.*

FDA Label Image

Figure1 (Guanfacine Figure 1)

This graph compares plasma concentration of Guanfacine (in ng/mL) over time (hours) for extended-release and immediate-release formulations at a 1 mg once daily dose. The immediate-release form shows a rapid peak around 3.5 ng/mL before declining, while the extended-release form exhibits a lower, more sustained plasma concentration over 24 hours.*

FDA Label Image

Figure 4 (Guanfacine Figure4)

A line graph showing treatment failure percentage over time (days) comparing two groups: placebo and SPD503. The x-axis represents time up to 203 days, and the y-axis represents the percentage of treatment failure. The placebo group shows a higher failure rate over time than the SPD503 group.*

FDA Label Image

Structure (Guanfacine Str)

Chemical structure of guanfacine hydrochloride depicted as a molecular diagram displaying the arrangement of atoms and bonds, including chlorine (Cl) atoms and functional groups relevant to guanfacine.*

FDA Label Image

Label Image (Lbl500907644)

Packaging label for GUANFACINE 3 mg extended-release oral tablets by A-S Medication Solutions, Libertyville, IL. The label states each tablet contains 3 mg of guanfacine hydrochloride, and the package contains 90 tablets. Storage instructions specify to keep at 68 to 77 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.